UnitedHealth Group Incorporated (UNH)
UnitedHealth Group (UNH) Rises As Market Takes a Dip: Key Facts
In the latest trading session, UnitedHealth Group (UNH) closed at $516.04, marking a +0.06% move from the previous day.
Here's one healthcare name this strategist says is buy, and another to avoid
In the latest Good Buy or Goodbye, Regan Capital chief investment officer Skyler Weinand joins Market Domination host Julie Hyman to break down which stock is a good buy and what stock should be avoided. Weinand recommends investing in UnitedHealth Group (UNH), as the company is trading at an attractive P/E ratio.
UnitedHealth Group: Will 2025 Finally Be A Normal Year?
UnitedHealth Group has shown unparalleled resiliency, growing adjusted earnings by over 10% despite facing significant headwinds, making it a 'Buy' at historical lows. The company endured a tough period with regulatory scrutiny, higher utilization rates, a cyberattack, and the tragic shooting of a key executive. Q4 marked a bottom for growth and profitability, with revenues of $101 billion and adjusted EPS of $6.74, showing mixed segment profitability.
UnitedHealth has scrapped mentions of DEI from website, TechCrunch reports
UnitedHealth Group has removed most mentions of its diversity, equity and inclusion (DEI) policies from its website, TechCrunch reported on Wednesday.
UnitedHealth removes mentions of DEI from its website
UnitedHealth Group has scrubbed much of its website mentioning its diversity, equity, and inclusion (DEI) policies, including pulling down blog posts and removing large sections from its website, TechCrunch has learned.
UnitedHealth Group (UNH) Surpasses Market Returns: Some Facts Worth Knowing
The latest trading day saw UnitedHealth Group (UNH) settling at $516.85, representing a +1.09% change from its previous close.
UnitedHealth's Optum Rx & EPN Team Up for Fairer Pharmacy Payments
UNH and EPN join forces to enhance pharmacy reimbursement, ensuring fair payments and better stability for independent pharmacies.
UnitedHealth Shares Rise 1.8% After Key Signal
UNH CLIMBS HIGHER ON DOWN DAY FOR BROAD MARKET
Should You Invest in UnitedHealth (UNH) Based on Bullish Wall Street Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to UnitedHealth (UNH). This makes it worthwhile to examine what the stock has in store.
Is UnitedHealth Stock Still a Buy Despite Its Premium Price Tag?
UNH is making significant investments in AI and digital tools to enhance consumer experiences and streamline healthcare processes.
UnitedHealth's unit reduces prescription reauthorization requirements by up to 25%
UnitedHealth Group's pharmacy benefit manager, Optum Rx, will eliminate up to 25% of the annual reauthorization requirements for certain drugs, lowering the need of prior authorizations required before patients can access the drugs, the company said on Wednesday.
